Discovery of novel immune checkpoint regulators in a comprehensive library of human extracellular proteins

Meeting abstracts Identification of novel targets in cancer immunotherapy is needed to address the significant number of patients that either do not respond to current therapies or encounter unacceptable toxicities. The discovery of such targets, including novel checkpoint regulators and the